Fishers, IN, United States of America

Jeffrey Alan Kyle


Average Co-Inventor Count = 14.4

ph-index = 8

Forward Citations = 142(Granted Patents)


Company Filing History:


Years Active: 2000-2006

Loading Chart...
18 patents (USPTO):Explore Patents

Title: Unveiling the Innovative Mind of Jeffrey Alan Kyle

Introduction:

Jeffrey Alan Kyle, a prolific inventor based in Fishers, IN (US), has made significant contributions in the field of pharmaceuticals and factor Xa inhibitors. With an impressive portfolio of 18 patents, Kyle's groundbreaking work has not gone unnoticed in the industry.

Latest Patents:

1. Aromatic amides: Kyle's recent patent application focuses on a compound designed as an inhibitor of factor Xa, with potential applications in pharmaceutical compositions. The patent encompasses the compound's synthesis process and related intermediates.

2. Antithrombotic amides: Another noteworthy patent application by Kyle revolves around a compound intended to act as an inhibitor of factor Xa. The patent includes the compound's formula, pharmaceutical compositions, and the process for its preparation.

Career Highlights:

Having worked at renowned companies like Eli Lilly and Company, Kyle has honed his skills and expertise in the pharmaceutical sector. His innovative approach to drug development and factor Xa inhibitors has led to groundbreaking advancements in the field.

Collaborations:

Throughout his career, Kyle has had the privilege of collaborating with esteemed professionals such as Valentine Joseph Klimkowski and John Joseph Masters. These collaborations have fueled creativity and fostered a culture of innovation in Kyle's work.

Conclusion:

In conclusion, Jeffrey Alan Kyle stands out as a visionary inventor with a keen focus on pharmaceutical innovations and factor Xa inhibitors. With a trail of 18 patents to his name and a history of successful collaborations, Kyle continues to push the boundaries of scientific discovery in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…